Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: A meta-analysis

Pediatric Radiology

Volumn 42, Issue 11, 2012, Pages 1372-1379

  Treglia, Giorgio ^a   Mirk, Paoletta ^b   Giordano, Alessandro ^a   Rufini, Vittoria ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Istituto di Radiologia di Universita Cattolica del Sacro Cuore di Roma   (Italy)

Author keywords

Congenital hyperinsulinism; Fluorine 18 dihydroxyphenylalanine; Meta analysis; PET CT; Positron emission tomography

Indexed keywords

6 FLUORODOPA F 18;

AREA UNDER THE CURVE; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; META ANALYSIS; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

CONGENITAL HYPERINSULINISM; DIHYDROXYPHENYLALANINE; EVIDENCE-BASED MEDICINE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84872269935     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-012-2459-2     Document Type: Article

References (24)

1. Arnoux JB, Verkarre V, Saint-Martin C et al (2011) Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis 6:63
2. Arnoux JB, de Lonlay P, Ribeiro MJ et al (2010) Congenital hyperinsulinism. Early Hum Dev 86:287-294
3. Barthlen W, MohnikeW, Mohnike K (2011) Techniques in pediatric surgery: congenital hyperinsulinism. Horm Res Paediatr 75:304-310
4. Pierro A, Nah SA (2011) Surgical management of congenital hyperinsulinism of infancy. Semin Pediatr Surg 20:50-53
5. Rahier J, Guiot Y, Sempoux C (2011) Morphologic analysis of focal and diffuse forms of congenital hyperinsulinism. Semin Pediatr Surg 20:3-12
6. Flanagan SE, Kapoor RR, Hussain K (2011) Genetics of congenital hyperinsulinemic hypoglycemia. Semin Pediatr Surg 20:13-17
7. Weckesser M (2009) Molecular imaging with positron emission tomography in paediatric oncology - FDG and beyond. Pediatr Radiol 39(Suppl 3):450-455
8. Ismail D, Hussain K (2010) Role of 18 F-DOPA PET/CT imaging in congenital hyperinsulinism. Rev Endocr Metab Disord 11:165-169
9. Mohnike W, Barthlen W, Mohnike K et al (2011) Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L- dihydroxyphenylalanine in congenital hyperinsulinism. Semin Pediatr Surg 20:23-27
10. Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1-e34
11. Whiting PF, Weswood ME, Rutjes AW et al (2006) Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6:9
12. Glas AS, Lijmer JG, PrinsMHet al (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129-1135
13. Zamora J, Abraira V, Muriel A et al (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31
14. Banerjee I, Skae M, Flanagan SE et al (2011) The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endocrinol 164:733-740
15. Hardy OT, Hernandez-Pampaloni M, Saffer JR et al (2007) Diagnosis and localization of focal congenital hyperinsulinism by 18 Ffluorodopa PET scan. J Pediatr 150:140-145
16. de Lonlay P, Simon-Carre A, Ribeiro MJ et al (2006) Congenital hyperinsulinism: pancreatic [18 F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab 91:933-940
17. Ribeiro MJ, De Lonlay P, Delzescaux T et al (2005) Characterization of hyperinsulinism in infancy assessed with PET and 18 Ffluoro- L-DOPA. J Nucl Med 46:560-566
18. Otonkoski T, Näntö-Salonen K, Seppänen M et al (2006) Noninvasive diagnosis of focal hyperinsulinism of infancy with [18 F]- DOPA positron emission tomography. Diabetes 55:13-18
19. Ribeiro MJ, Boddaert N, Bellanné-Chantelot C et al (2007) The added value of [18 F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Eur J Nucl Med Mol Imaging 34:2120-2128
20. Hardy OT, Hernandez-Pampaloni M, Saffer JR et al (2007) Accuracy of [18 F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 92:4706-4711
21. Barthlen W, Blankenstein O, Mau H et al (2008) Evaluation of [18 F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab 93:869-875
22. Capito C, Khen-Dunlop N, Ribeiro MJ et al (2009) Value of 18 Ffluoro- L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism. Radiology 253:216-222
23. Masue M, Nishibori H, Fukuyama S et al (2011) Diagnostic accuracy of [18F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan. Clin Endocrinol 75:342-346
24. Zani A, Nah SA, Ron O et al (2011) The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy. J Pediatr Surg 46:204-208